Delivery Order SPE2DB20D9331-SPE2DB25FL1X5
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,124.68 by the Defense Logistics Agency (DLA) on September 16, 2025, for the supply of Mirena 52 mg contraceptive systems. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 7, 2025, and carries no set-aside designation. This award represents a single transaction under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a discrete purchase under the company's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,645.00 by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Mirena 52 mg contraceptive systems. The contract utilizes firm fixed-price pricing with an ultimate completion date of June 24, 2025, and is not designated as a set-aside award. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $2,603.85 by the Defense Logistics Agency (DLA) for Mirena 52 mg contraceptive systems. The delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a tactical procurement under the DLA's broader pharmaceutical supply infrastructure. This award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 19, 2025, valued at $1,562.31 for Mirena 52 mg systems by the Defense Logistics Agency (DLA). This firm fixed-price delivery order, with an ultimate completion date of October 10, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,207.70 by the Defense Logistics Agency for Mirena 52 mg systems. The contract, awarded on September 15, 2025, with an ultimate completion date of October 6, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Mirena 52 mg systems, with a ceiling value of $1,041.56. The award, issued on August 6, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 27, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency for 52 mg Mirena systems valued at $1,562.31. The award, issued on September 16, 2025, with an ultimate completion date of October 7, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,811.55 by the Defense Logistics Agency's Medical Supply Chain on May 23, 2025. The delivery order covers Mirena 20 mcg/24 hr contraceptive implants, with an ultimate completion date of June 11, 2025. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $26,038.50 by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, which is scheduled for completion by September 22, 2025, was issued without a set-aside designation, allowing the contractor to compete on an unrestricted basis. The award represents a specific...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1X5Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $10,415.40 by the Defense Logistics Agency on September 5, 2025, for the supply of Mirena 52 mg systems. The contract, which carries no set-aside designation, is scheduled for ultimate completion by September 26, 2025, with performance occurring at the vendor's Park Ridge facility. This delivery order represents a discrete procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, valued at approximately $500 million through November 2026, which authorizes the issuance of firm fixed-price orders for pharmaceutical products supporting military healthcare facilities worldwide. The Defense Logistics Agency, responsible for supply chain management for the Department of Defense, utilizes this contracting vehicle to procure essential medical supplies and medications for military health systems. DMS Pharmaceutical Group's robust portfolio with the DLA encompasses an extensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables. The Mirena delivery—a hormonal contraceptive implant—exemplifies the company's specialization in providing comprehensive pharmaceutical solutions that support the healthcare needs of military personnel and veterans across the federal system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 9/5/25 |